QID 730417

QID 730417: Palo Alto Networks (PAN-OS) Impact of Spring Vulnerabilities CVE-2022-22963 and CVE-2010-1622 Bypass Vulnerability (PAN-191178)

PAN OS is the software that runs all Palo Alto Networks next-generation firewalls.

The Palo Alto Networks Product Security Assurance team is evaluating the Spring Cloud Function vulnerability (CVE-2022-22963) and Spring Core vulnerability (CVE-2010-1622 bypass) as it relates to our products. This is a developing product security incident and additional product status could be added and changed as more information becomes available.

Affected Versions:


QID Detection Logic (Authenticated):

This QID looks for the vulnerable version of PAN-OS

The Palo Alto Networks Product Security Assurance team is evaluating the Spring Cloud Function vulnerability (CVE-2022-22963) and Spring Core vulnerability (CVE-2010-1622 bypass) as it relates to our products. This is a developing product security incident and additional product status could be added and changed as more information becomes available.

  • CVSS V3 rated as Critical - 8.6 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution

    Refer to PAN-191178 for more information about patching this vulnerability.



    Workaround:
    No workarounds or mitigations are required for Palo Alto Networks products at this time.

    Vendor References

    CVEs related to QID 730417

    CVE-2022-22963 |
    Software Advisories
    Advisory ID Software Component Link
    PAN-191178 URL Logo security.paloaltonetworks.com/CVE-2022-22963
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].